Lawyer profile
Steve Abrams
Hogan Lovells
- Firm
- Hogan Lovells
- Practice
- capital markets, Capital Markets, Life Sciences and Health Care
- Office
- Philadelphia
- Active in the record
- 2021 to 2026
Deal experience
Deals
8 announced deals in the record Hogan Lovells advises Definium Therapeutics, Inc. in Upsized Public Offering 30 Jun 2026
Hogan Lovells advises MindMed in its US$259 million public offering 5 Nov 2025
Hogan Lovells Guides Mind Medicine Inc. on its US$75m Underwritten Public Offering 14 Aug 2024
Hogan Lovells advises Perspective Therapeutics in its US$80 million underwritten offering of equity securities 4 Jun 2024
Hogan Lovells represents Optinose in its US$55 million registered direct offering 30 May 2024
Hogan Lovells advises EyePoint Pharmaceuticals on its $230 million follow-on public offering of common stock 9 Dec 2023
Hogan Lovells advises Soliton in US$550 million acquisition by AbbVie’s Allergan Aesthetics 14 May 2021
Hogan Lovells assists EyePoint Pharmaceuticals on transformative follow-on public offering of common stock 9 Feb 2021
Deal alerts PRO
Get an email when Steve Abrams is named on a newly announced deal.
Alerts come as one daily email at most.
Analytics
Based on announced deals in DealDatabaseLoading analytics…
Complete deal history
Is this you?
Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.
Claim this profile